Ekso Bionics considers the CMS approval to positively impact...

Moomoo AI Dec 12, 2023 08:01

Ekso Bionics considers the CMS approval to positively impact SCI patients' health outcomes by increasing affordability of Ekso Indego Personal. This decision is expected to expand the patient population, potentially boosting product sales.

Press Release: Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

2122 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

3859Followers

0Following

8828Visitors